Details for New Drug Application (NDA): 070867
✉ Email this page to a colleague
NDA 070867 describes VINCREX, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. Additional details are available on the VINCREX profile page.
The generic ingredient in VINCREX is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.
The generic ingredient in VINCREX is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.
Summary for 070867
| Tradename: | VINCREX |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | vincristine sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 070867
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5MG/VIAL | ||||
| Approval Date: | Jul 12, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
